Home > Income Statement > NEULAND LABORATORIES

NEULAND LABORATORIES
Consolidated Net Profit

    Back to Income Statement
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Consolidated Net Profit ₹364 Cr₹260 Cr₹300 Cr₹164 Cr₹64 Cr

What is the latest Consolidated Net Profit of NEULAND LABORATORIES ?

The latest Consolidated Net Profit ratio of NEULAND LABORATORIES is ₹364 Cr based on Mar2026 Consolidated results.
Year Consolidated Net Profit
Mar2026₹364 Cr
Mar2025₹260 Cr
Mar2024₹300 Cr
Mar2023₹164 Cr
Mar2022₹64 Cr

How is Consolidated Net Profit of NEULAND LABORATORIES Trending?

Years Consolidated Net Profit % Change
Mar2026 ₹364 Cr
39.94
Mar2025 ₹260 Cr
-13.32
Mar2024 ₹300 Cr
83.51
Mar2023 ₹164 Cr
156.21
Mar2022 ₹64 Cr -

Compare Consolidated Net Profit of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹25,862.1 Cr 2.2% -1.8% 15.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹454,914.0 Cr 3.9% 7.8% 13% Stock Analytics
DIVIS LABORATORIES ₹300,380.0 Cr 11.5% 20.6% 68% Stock Analytics
TORRENT PHARMACEUTICALS ₹181,169.0 Cr 1% 1.8% 34.3% Stock Analytics
DR REDDYS LABORATORIES ₹114,933.0 Cr 1.1% 11.8% 14.9% Stock Analytics
CIPLA ₹114,478.0 Cr 1.1% 7.9% -6.3% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

2.2%

-1.8%

15.8%

SENSEX

5.9%

13%

-1.9%


You may also like the below Video Courses